Oklahoma drops several claims in opioid case against J&J, Teva

Oklahoma's attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva Pharmaceutical Industries Ltd in a closely watched lawsuit alleging the drugmakers helped fuel the U.S. opioid epidemic.

Australian opposition's promise for health spending buoys stocks

Shares in Australian medical imaging and cancer-treatment firms rose on Friday after the opposition Labor party promised increased spending in the sector, weeks out from an election that opinion polls suggest they will win in a landslide.

Major study debunks myth that moderate drinking can be healthy

Blood pressure and stroke risk rise steadily the more alcohol people drink, and previous claims that one or two drinks a day might protect against stroke are not true, according to the results of a major genetic study.

Drugmakers Jazz, Alexion, Lundbeck to pay $123 million to resolve U.S. charity kickback probe

Three drugmakers will pay $122.6 million to resolve claims they used charities that help cover Medicare patients' out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging use of their medications, including some expensive ones.

Novartis, Amgen in dispute over migraine drug partnership

Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotechnology company of trying to wrongfully back out of agreements to jointly develop and market the migraine prevention drug Aimovig and keep the profits for itself.

Moderate muscle strength tied to lower risk of diabetes

Maintaining a moderate amount of muscle strength may help adults lower their risk of developing type 2 diabetes, a U.S. study suggests.

No U.S. labs follow all guidelines for 'cell-free' prenatal testing

Not even one of the commercial labs offering "cell-free" noninvasive prenatal screening for chromosomal disorders is fully following the recommendations published by the American College of Medical Genetics, according to a new report.

Health Canada plans to suspend Allergan's breast implant license

Health Canada plans to suspend the license for Allergan Plc's Biocell breast implant due to the risk of a rare cancer linked to such implants, the regulator said in a notice to the Botox-maker on Thursday.

Drug company founder, execs exploited patients to sell opioid: U.S. prosecutor

The founder of Insys Therapeutics Inc put profits over patient safety by bribing doctors to prescribe an addictive fentanyl spray, fueling the U.S. opioid epidemic, a federal prosecutor said on Thursday at the end of a landmark trial.

Starting workouts in middle age tied to longer life

(Reuters Health) - While regularly exercising over the course of decades is a great way to live longer, a U.S. study suggests that even people who don't start working out until middle-age may see similar longevity benefits.

How cannabis is firing up the U.S. supply chain

U.S. companies cannot stop talking about marijuana, hoping in part they can catch investor interest as the booming economy around the drug lifts revenues throughout the supply chain.

Related Videos

French museum renames paintings after black models

Tributes pour in for late rapper Nipsey Hussle

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS